Progressive degeneration in the cochlear nucleus after chemical destruction of the cochlea

Area of Science:

• Ototoxicity and Neurodegeneration Research
• Auditory System Physiology
• Pharmacological Effects on Inner Ear

Background:

• Gentamicin is an aminoglycoside antibiotic with known ototoxic potential.
• Damage to the organ of Corti and spiral ganglion cells can lead to hearing loss.
• The effects of gentamicin on the central auditory pathway, specifically the antero-ventral cochlear nucleus (AVCN), require detailed investigation.

Purpose of the Study:

• To investigate the ultrastructural changes in the antero-ventral cochlear nucleus (AVCN) following gentamicin-induced ototoxicity.
• To determine the pattern and timeline of neurodegeneration in the AVCN after gentamicin administration.
• To assess whether gentamicin exerts a direct or indirect neurotoxic effect on AVCN cell bodies.

Main Methods:

• Guinea pigs were administered gentamicin directly into the inner ear.
• The organ of Corti and spiral ganglion cells were destroyed.
• The antero-ventral cochlear nucleus (AVCN) was examined using electron microscopy at 15 and 30 days post-treatment.

Main Results:

• No specific pattern of degeneration was observed in the AVCN.
• Progressive degeneration of nerve terminals was noted, with initial swelling at 15 days and electron-dense changes at 30 days.
• The cell bodies of the AVCN remained unaltered, suggesting no rapid direct or indirect neurotoxic effect.

Conclusions:

• Gentamicin-induced ototoxicity leads to progressive degeneration of nerve terminals in the AVCN.
• The AVCN cell bodies appear resistant to the neurotoxic effects of gentamicin.
• These findings contribute to understanding the central auditory pathway's response to aminoglycoside-induced inner ear damage.